Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 275 results for "fda"

Ajanta Pharma gets USFDA observation for Paithan facility
Money Control

Dr Reddy's unit fails to clear US FDA audit

The US drugs regulator had issued a warning letter to three of firm manufacturing facilities Business Standard, 19 hours ago
USFDA inspects Cadila Healthcare's Moraiya facility Business Standard, 6 days ago
[x]  

5,730 images for fda

Med India, 2 days ago
Money Control, 1 day ago
Business Standard, 5 days ago
Reuters, 6 days ago
Reuters, 1 day ago
Med India, 6 days ago
PharmaVOICE, 2 weeks ago
Live Trading News, 2 weeks ago
Cancer Therapy Advisor, 2 weeks ago
McKnight's Long Term Care News, 2 weeks ago
Money Control

Glenmark Pharma's Ankleshwar plant gets 4 FDA observations

Glenmark Pharmaceuticals today said it has received four observations from the US health regulator for its Ankleshwar facility after inspection in December 2016.
 DNA1 day ago
Business Standard

Biocon at new high; FDA accepts BLA for biosimilar Pegfilgrastim

Biocon shares gained 2.6 percent to hit a record high of Rs 1,123 after the US health regulator USFDA has accepted pharma major Mylan's biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim.
 Money Control5 days ago US FDA accepts application of Mylan & Biocon for biosimilar pegfilgrastim  Business Standard5 days ago FDA accepts Mylan's BLA for proposed biosimilar Pegfilgrastim  DNA5 days ago US nod for Biocon-Mylan biosimilar  Business Line1 month ago

Analysts give a thumbs-up to Cadila on resolution of FDA warning

Brokerage firms and analysts tracking the stock welcomed the development and most have raised the target price. To be sure a lot of them were expecting resolution of the warning letter on Moraiya facility in the fourth quarter of FY17.
 Money Control5 days ago

BUZZ-India's Cadila Healthcare surges; U.S. FDA unit inspection ends successfully

** Shares of Cadila Healthcare Ltd surge as muchas 18.3 pct, their highest since Nov 1, 2016 ** U.S. health regulator finds no adverse observationsduring inspection at the company's Moraiya facility http://bit.ly/2kMMsam ** Stock posts biggest intraday ...
 Sify6 days ago Cadila shares extend gains; surge over 7 pc  Business Standard5 days ago

Cadila Healthcare inches closer to net profit upgrades

The company is on course to sort out various issues raised by the FDA
 Business Standard5 days ago

ANALYSIS-Pharma industry shuns Trump push for radical shift at FDA

U. S. President Donald Trump's vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new ...
 DNA1 week ago Pharma industry shuns Trump push for radical shift at FDA  Reuters1 week ago

Illegal medical devices worth ₹1 crore seized

FDA officials received a tip-off about the devices being stocked in a room on GT Hospital premises. The officials raided a staff quarters on February 2 and found that an unlicensed firm, Medicol Surgical and Hospital Equipments, was being run there by Vineet ...
 The Hindu2 weeks ago FDA seizes unlicensed medical devices worth over Rs 1 crore  DNA2 weeks ago FDA seize f?ake? cosmetics worth ?Rs ?2.5 crore? ?  DNA1 month ago Rs 2.5 crore worth spurious cosmetics seized by FDA  Business Standard1 month ago

Glenmark's blood pressure drug gets US FDA nod; shares up 1%

The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
 Money Control1 month ago Panacea Biotec up 13 pct on US FDA nod for migraine drug  Business Standard1 month ago Panacea Biotec up 13% on US FDA nod for migraine drug  Money Control1 month ago
Rediff.com

Indian-American entrepreneur under consideration to lead FDA

Indian-American Balaji SSrinivasan, a successful Silicon Valley-based entrepreneur andCEO of a bitcoin startup, is under consideration for TrumpAdministration's pick to lead the Federal Drug Administrationafter he met the US President-elect.
 Money Control1 month ago Indian American could be FDA head under Trump  The Hindu1 month ago Trump considering Indian-American to lead FDA  Rediff.com1 month ago Indian American on Trump probables list for USFDA chief  Business Line1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less